Navigation Links
Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal
Date:11/20/2007

SYDNEY, Australia, Nov. 20 /PRNewswire/ -- Open access online journal, AZoJono* (The AZo Journal of Nanotechnology Online) has released a special nanotubes research edition in conjunction with DESYGN-IT*, an EU funded collaborative research project that has been investigating the design, synthesis, growth and application of nanotubes, nanowires and nanotube arrays for industrial applications.

URL for special edition [http://www.azonano.com/nanotechnology%20journal.asp]

DESYGN-IT, is a collaborative research project between a number of Universities and SME partners from several of the member states of the EU.

The AZoJono special edition comprises seven research articles that focus on cutting edge carbon nanotube research, in particular the characterisation of nanotubes and their products. Applications areas discussed include the lithographic stamping of computer chips, connector wires for computer chips, flat screen displays, catalysts, electrodes, nanowires, miniature actuators and reinforced composite materials.

Professor Werner Blau from Trinity College Dublin, a leader in carbon nanotube research and the DESYGN-IT project co-ordinator stated, "We are very pleased to be able to release these papers online through the open access journal, AZoJono. For some time now, I've been well aware of how effective AZoJono is at distributing the latest Nanotech research findings to a large global audience."

AZoNano.com Chief Editor David Freund commented, "It is very pleasing to see the recognition that AZoJono is now receiving from leading Nanotech researchers such as the DESYGN-IT team. Some of our most popular Nanotech papers have now received over 40,000 page views and an involvement with groups such as DESYGN-IT confirms that AZoJono's open access approach using our patented OARS (Open Access Author Rewards) system is starting to gain some significant traction as a highly successful mechanism for researchers to broadcast their findings to the global Nanotech community."

About DESYGN-IT

Members of DESYGN-IT include Trinity College Dublin, National University of Ireland Cork, Jozef Stefan Institute, University of Ulster, Queen Mary and Westfield College, Queen University Belfast, Fraunhofer-Gesellschaft, University of Cambridge, Toughglass, Sensor Technology & Devices, Mid Sweden University, Ntera, Mo6 and University of Latvia.

About AZoJono

AZoJono - The AZo Journal of Nanotechnology Online [http://www.azonano.com/nanotechnology.asp] is published online at AZoNano.com - The A to Z of Nanotechnology - a site operated by AZoNetwork, Sydney Australia [http://www.azonetwork.com]. AZoJono publishes high quality articles and papers on all aspects of nanotechnology.

CONTACT:

Dr. Ian Birkby

AZoNetwork

Tel: +61-2-9999-0070

Fax: +61-2-9999-0071

e-mail: ianbirkby@azonetwork.com


'/>"/>
SOURCE AZoNetwork
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Laboratory at UI plays major role in diagnosing cancer
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. Major grant advances UWs clinical and translational research enterprise
7. Major differences revealed in how local authorities in the UK support disabled people
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
11. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger ... Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport ... attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... , ... Coppin Insurance Agency, an insurance and financial planning firm based in ... area, is embarking on a charity drive with the goal of providing support and ... Food Bank of Southwest Florida works to provide fresh and nutritious food free of ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
(Date:12/8/2016)... DANVILLE, Pa. , Dec. 8, 2016  A ... physicians reports that the use of opioid therapy to ... actually increase the likelihood of more harmful consequences, including ... Davis , M.D., and Zankhana Mehta , M.D., ... current research on chronic opioid therapy. The study was ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
Breaking Medicine Technology: